For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit


Found 19 results
Author Title [ Type(Desc)] Year
Filters: Author is Wernicke, A Gabriella  [Clear All Filters]
Journal Article
Mann J, Ramakrishna R, Magge R, A Wernicke G.  2017.  Advances in Radiotherapy for Glioblastoma.. Front Neurol. 8:748.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..  2017.  Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..  2017.  Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
A Wernicke G, Yondorf MZ, Parashar B, Nori D, Chao KSClifford, Boockvar JA, Pannullo S, Stieg P, Schwartz TH.  2016.  The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.. J Neurooncol. 127(1):145-53.
A Wernicke G, Taube S, Smith AW, Herskovic A, Parashar B, Schwartz TH.  2020.  Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.. Brachytherapy. 19(5):705-712.
Yondorf MZ, Faraz S, Smith AW, Sabbas A, Parashar B, Schwartz TH, A Wernicke G.  2020.  Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases.. J Contemp Brachytherapy. 12(4):311-316.
Mahase SS, Navrazhina K, Schwartz TH, Parashar B, A Wernicke G.  2019.  Intraoperative brachytherapy for resected brain metastases.. Brachytherapy. 18(3):258-270.
Julie DA, Lazow SP, Vanderbilt DB, Taube S, Yondorf MZ, Sabbas A, Pannullo S, Schwartz TH, A Wernicke G.  2020.  A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.. J Neurosurg. :1-8.
Pham A, Yondorf MZ, Parashar B, Scheff RJ, Pannullo SC, Ramakrishna R, Stieg PE, Schwartz TH, A Wernicke G.  2016.  Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.. J Neurooncol. 127(1):63-71.
Eljalby M, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G.  2019.  Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases.. World Neurosurg. 127:397-404.
Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G.  2019.  An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.. Seizure. 70:30-37.
Shafiq ARaza, A Wernicke G, Riley CAlex, Morgenstern PF, Nedialkova L, Pannullo SC, Parashar B, Magge R, Schwartz TH.  2019.  Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.. J Neurosurg. 132(3):921-926.
Yondorf MZ, Schwartz TH, Boockvar JA, Pannullo S, Stieg P, Sabbas A, Pavese A, Trichter S, Nedialkova L, Parashar B et al..  2017.  Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors.. Health Phys. 112(4):403-408.
Chidambaram S, Pannullo SC, Schwartz TH, A Wernicke G.  2019.  Reirradiation of Recurrent Brain Metastases: Where Do We Stand? World Neurosurg. 125:156-163.
Yuan M, Behrami E, Pannullo S, Schwartz TH, A Wernicke G.  2019.  The Relationship Between Tumor Volume and Timing of Post-resection Stereotactic Radiosurgery to Maximize Local Control: A Critical Review.. Cureus. 11(9):e5762.
A Wernicke G, Yondorf M, Parashar B, Trichter S, Schwartz TH.  2015.  Response.. J Neurosurg. 123(4):1111-2.
Hirschfeld CB, Schwartz TH, Parashar B, A Wernicke G.  2016.  Seed migration to the spinal canal after postresection brachytherapy to treat a large brain metastasis.. Brachytherapy. 15(5):637-41.
A Wernicke G, Lazow SP, Taube S, Yondorf MZ, Kovanlikaya I, Nori D, Christos P, Boockvar JA, Pannullo S, Stieg PE et al..  2016.  Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.. Oper Neurosurg (Hagerstown). 12(1):49-60.
O'Brien DARoth, Poppas P, Kaye SM, Mahase SS, An A, Christos PJ, Liechty B, Pisapia D, Ramakrishna R, A Wernicke G et al..  2021.  Timing of Adjuvant Fractionated Stereotactic Radiosurgery Impacts Local Control of Resected Brain Metastases.. Pract Radiat Oncol.